ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice

Journal of Lipid Research

Volumn 49, Issue 9, 2008, Pages 2013-2022

  Chen, Zhouji ^a   Newberry, Elizabeth P ^a   Norris, Jin Y ^a   Xie, Yan ^a   Luo, Jianyang ^a   Kennedy, Susan M ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ApoB mRNA editing; Apobec1; Hepatic steatosis; VLDL secretion

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; COMPLEMENTARY DNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CARRIER PROTEIN; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FEMALE; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER CELL; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; LIVER MICROSOME; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SECRETION;

ANIMALS; APOLIPOPROTEIN B-100; CARRIER PROTEINS; FEMALE; LIPOPROTEINS, VLDL; MALE; MICE; MICE, OBESE; MICROSOMES, LIVER; TRIGLYCERIDES;

EID: 53149150247     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800240-JLR200     Document Type: Article

References (38)

1. Blasiole, D. A., R. A. Davis, and A. D. Attie. 2007. The physiological and molecular regulation of lipoprotein assembly and secretion. Mol. Biosyst. 3: 608-619.
2. Davidson, N. O., and G. S. Shelness. 2000. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
3. Chen, Z., and N. O. Davidson. 2006. Genetic Regulation of Intestinal Lipid Transport and Metabolism. In Physiology of the Gastrointestinal Tract. 4th Edition. LR Johnson, editor. Academic Press. Boston. 1711-1734.
4. Hussain, M. M., J. Shi, and P. Dreizen. 2003. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J. Lipid Res. 44: 22-32.
5. Kim, E., and S. G. Young. 1998. Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39: 703-723.
6. Farese, R. V., Jr., S. L. Ruland, L. M. Flynn, R. P. Stokowski, and S. G. Young. 1995. Knockout of the mouse apolipoprotein B genes results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl. Acad. Sci. USA. 92: 1774-1778.
7. Raabe, M., L. M. Flynn, C. H. Zlot, J. S. Wong, M. M. Véniant, R. L. Hamilton, and S. G. Young. 1998. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. USA. 95: 8686-8691.
8. Jamil, H., D. A. Gordon, D. C. Eustice, C. M. Brooks, J. K. J. Dickson, Y. Chen, B. Ricci, C. H. Chu, T. W. Harrity, C. P. J. Ciosek, et al. 1996. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. USA. 93: 11991-11995.
9. Wang, Y., R. S. McLeod, and Z. Yao. 1997. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells. J. Biol. Chem. 272: 12272-12278.
10. Kulinski, A., S. Rustaeus, and J. E. Vance. 2002. Microsomal triglyceride transfer protein is required for lumenal accretion of triacylglycerol not associated with apoB, as well as for apoB lipidation. J. Biol. Chem. 277: 31516-31525.
11. Larsson, S. L., J. Skogsberg, and J. Bjorkegren. 2004. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. J. Biol. Chem. 279: 831-836.
12. Raabe, M., M. M. Véniant, M. A. Sullivan, C. H. Zlot, J. Björkegren, L. B. Nielsen, J. S. Wong, R. L. Hamilton, and S. G. Young. 1999. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103: 1287-1298.
13. Leung, G. K., M. M. Veniant, S. K. Kim, C. H. Zlot, M. Raabe, K. Bjorkegren, R. A. Neese, M. K. Hellerstein, and S. G. Young. 2000. A deficiency of microsomal triglyceride transfer protein reduced apolipoprotein B secretion. J. Biol. Chem. 275: 7515-7520.
14. Yen, T. T., J. A. Allan, P. L. Yu, M. A. Acton, and D. V. Pearson. 1976. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/ a mice. Biochim. Biophys. Acta. 441: 213-220.
15. Memon, R. A., J. Fuller, A. H. Moser, P. J. Smith, C. Grunfeld, and K. R. Feingold. 1999. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes. 48: 121-127.
16. Wiegman, C. H., R. H. Bandsma, M. Ouwens, F. H. van der Sluijs, R. Havinga, T. Boer, D. J. Reijngoud, J. A. Romijn, and F. Kuipers. 2003. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes. 52: 1081-1089.
17. Li, X., S. M. Grundy, and S. B. Patel. 1997. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J. Lipid Res. 38: 1277-1288.
18. Wolfrum, C., and M. Stoffel. 2006. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 3: 99-110.
19. Bartels, E. D., M. Lauritsen, and L. B. Nielsen. 2002. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes. 51: 1233-1239.
20. Chen, Z., R. L. Fitzgerald, M. R. Averna, and G. Schonfeld. 2000. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. J. Biol. Chem. 275: 32807-32815.
21. Chen, Z., R. L. Fitzgerald, G. Li, N. O. Davidson, and G. Schonfeld. 2004. Hepatic secretion of apoB-100 is impaired in hypobetalipo-proteinemic mice with an apoB-38.9-specifying allele. J. Lipid Res. 45: 155-163.
22. Hirano, K-I., S. G. Young, R. V. Farese, Jr., J. Ng, E. Sande, C. Warburton, L-M. Powell-Braxton, and N. O. Davidson. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipo-protein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271: 9887-9890.
23. Nielsen, L. B., S. P. McCormick, V. Pierotti, C. Tam, M. D. Gunn, H. Shizuya, and S. G. Young. 1997. Human apolipoprotein B transgenic mice generated with 207- and 145-kilobase pair bacterial artificial chromosomes. Evidence that a distant 51-element confers appropriate transgene expression in the intestine. J. Biol. Chem. 272: 29752-29758.
24. Borensztajn, J., M. S. Rone, and T. J. Kotlar. 1976. The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by Triton WR-1339. Biochem. J. 156: 539-543.
25. Ishikawa, T., and N. Vidge. 1979. Changes in the concentration of plasma lipoproteins and apoproteins following the administration of Triton WR 1339 to rats. J. Lipid Res. 20: 254-264.
26. Améen, C., U. Edvardsson, A. Ljungberg, L. Asp, P. Åkerblad, A. Tuneld, S-O. Olofsson, D. Lindén, and J. Oscarsson. 2005. Activation of peroxisome proliferator-activated receptor increases the expression and activity of microsomal triglyceride transfer protein in the liver. J. Biol. Chem. 280: 1224-1229.
27. Wetterau, J. R., and D. B. Zilversmit. 1984. A triglyceride and cholesteryl ester transfer protein associated with liver microsomes. J. Biol. Chem. 259: 10863-10866.
28. Xie, Y., E. P. Newberry, S. G. Young, S. Robine, R. L. Hamilton, J. S. Wong, J. Luo, S. Kennedy, and N. O. Davidson. 2006. Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. J. Biol. Chem. 281: 4075-4086.
29. -/-Mttp-IKO mice: a survival advantage for mammalian intestinal apoblipoprotein B mRNA editing. J. Biol. Chem. 282: 33043-33051.
30. Tietge, U. J., A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader. 1999. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 40: 2134-2139.
31. Nicodeme, E., F. Benoist, R. McLeod, Z. Yao, J. Scott, C. C. Shoulders, and T. Grand-Perret. 1999. Identification of domains in apolipoprotein B100 that confer a high requirement for the microsomal triglyceride transfer protein. J. Biol. Chem. 274: 1986-1993.
32. Petit, V., L. Arnould, P. Martin, M-C. Monnot, T. Pineau, P. Besnard, and I. Niot. 2007. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J. Lipid Res. 48: 278-287.
33. Taghibiglou, C., A. Carpentier, S. C. Van Iderstine, B. Chen, D. Rudy, A. Aiton, G. F. Lewis, and K. Adeli. 2000. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275: 8416-8425.
34. Carpentier, A., C. Taghibiglou, N. Leung, L. Szeto, S. C. Van Iderstine, K. D. Uffelman, R. Buckingham, K. Adeli, and G. F. Lewis. 2002. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J. Biol. Chem. 277: 28795-28802.
35. Grundy, S. M., A. Chait, and J. D. Brunzell. 1987. Familial combined hyperlipidemia workshop. Arteriosclerosis. 7: 203-207.
36. Gormsen, L. C., M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen. 2006. Energy expenditure, insulin, and VLDL-triglyceride production in humans. J. Lipid Res. 47: 2325-2332.
37. Mittendorfer, B., B. W. Patterson, S. Klein, and L. S. Sidossis. 2003. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am. J. Physiol. Endocrinol. Metab. 284: E708-E715.
38. Klein, S., B. Mittendorfer, J. C. Eagon, B. Patterson, L. Grant, N. Feirt, E. Seki, D. Brenner, K. Korenblat, and J. McCrea. 2006. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 130: 1564-1572.